Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 11,603Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 38EPIZYME INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 9889138

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-16

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 10155002

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-12

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 10245269

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2737

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-04-11

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 9688665

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-08-22

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 9549931

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-12

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 9855275

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-12

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 10420775

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-12

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 10369155

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-16

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 11052093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211723

Patent Use Code : U-2736

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-13

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

TAZEMETOSTAT HYDROBROMIDE

US Patent Number : 9889138

Drug Substance Claim :

Drug Product Claim :

Application Number : 211723

Patent Use Code : U-2852

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-10-16

blank